Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine

Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorised the companies’ XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) in individuals 5 years and older.

How did hospitalizations for mental health conditions in children change following the COVID-19 pandemic?

The incidence of mental health conditions in young people before and during Canada’s coronavirus disease 2019 (COVID-19) pandemic.

July 11, 2024

CMFI 2023: Advancing the fight against multi-resistant pathogens

CMFI 2023 addresses pressing challenges of our time, such as the rise of multi-resistant pathogens and the roles of microbes in causing or preventing major

September 5, 2023

The science behind children’s tendency to gather excessive information

Scientists have learned that children find it hard to focus on a task, and often take in information that won’t help them complete their assignment.

August 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.